# Alendronate

NDC: 10135-718
Generic name: Alendronate sodium tablet
Labeler / Manufacturer: Marlex Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20201201

FDA application: ANDA090258

## Active ingredients

- ALENDRONATE SODIUM: 35 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"10135-718"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=10135-718
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b63421af-ec03-1de7-e053-2a95a90abec6